SPOTLIGHT -
Vision by Design Conference 2023 announced by the American Academy of Orthokeratology and Myopia Control
The annual conference will take place September 6-9 at the Renaissance Schaumburg Convention Center in Schaumburg, IL.
iHealthScreen Inc. applies for FDA 510K Submission for iPredict
The iPredict AI Eye Screening System will provide a fully automated age-related macular degeneration (AMD) screening report in less than 60 seconds.
Comanagement of patients with keratoconus
Surgical interventions once disease progresses.
Comanagement of refractive surgeries: What are you waiting for?
Provide better, more cohesive patient care with comanagement.
This week in optometry: May 22-May 26
Catch up on what happened in optometry during the week of May 22-May 26.
New lens analysis approach could improve treatments for myopia
Instrumentation recreates properties of the myopic eye to test lenses that prevent visual decline.
Genentech, American Diabetes Association partner to improve access to screening and treatment for diabetic eye disease
As part of the American Diabetes Association's Health Equity Now program, the organization has partnered with Genentech, piloting a partnership within Alabama to specifically focusing on tackling barriers related to diabetic eye disease.
Alimera completes recruitment for its NEW DAY study
According to the company, the study has now reached its goal of 300 patients enrolled to evaluate ILUVIEN as a first line, baseline therapy for DME.
Digital health care evolves in the aftermath of the pandemic
Artificial intelligence is the future of optometric disease monitoring.
Alvotech and Polifarma join forces for proposed biosimilar to Eylea
The two companies have announced an exclusive agreement for Polifarma to commercialize AVT06, the proposed biosimilar to Eylea, in Turkey.
Stating the facts about combination myopia management treatments
Growing evidence supports dual therapy to slow progression.
Factors affiliated in increasing myopia rates identified
An epidemiologic study of myopia in a Chinese province found that economic status, gender, and age were associated with rates of myopia.
Q&A: What role do optometrists play in the treatment geographic atrophy?
Diagnose, monitor, comanage—optometrists support patients throughout all stages of the disease.
Newly approved Miebo holds power for the treatment of dry eye disease
This single-ingredient tear stabilizer from Bausch + Lomb and Novaliq could become the choice therapeutic for dry eye disease.
Adherence and persistence: When patients take their health into their own hands
Both are critical to successful treatment, but how can optometrists help?
This week in optometry: May 15-May 19
Catch up on what happened in optometry during the week of May 15-May 19.
ASCRS 2023: Laser scleral microporation from ACE Vision Group
Mitchell Jackson, MD, discussed laser scleral microporation from ACE Vision Group at the 2023 ASCRS annual meeting in San Diego.
New and emerging myopia management: Spectacles
Currently, there are several novel spectacle designs available across the world. Unfortunately, none of them are available in the US currently.
FDA approves Bausch + Lomb, Novaliq candidate NOV03 for signs and symptoms of dry eye disease
MIEBO, previously known as NOV03, is the first and only FDA-approved treatment for dry eye disease that targets tear evaporation.
ASCRS 2023: Aurion clinical trials of endothelial cell therapy injection
John Berdahl, MD, discussed the Aurion clinical trials of endothelial cell therapy injection at the 2023 ASCRS annual meeting in San Diego.
